Origen de la red de primer grado Marlies Sproll.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
35
| Public Company | Biotechnology | 35 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Marlies Sproll a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
Bayer Corp.
 Bayer Corp. Pharmaceuticals: MajorHealth Technology Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ. | Pharmaceuticals: Major | Director/Board Member | |
| BAYER AG | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| SANOFI | Biotechnology | Chief Tech/Sci/R&D Officer | |
| 4SC AG | Biotechnology | Investor Relations Contact Director/Board Member | |
| VERACYTE, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
Moleac Pte Ltd.
 Moleac Pte Ltd. Pharmaceuticals: MajorHealth Technology Moleac Pte Ltd. develops and distributes biopharmaceutical products. It operates as a bio-pharmaceutical company that develops new medicines for the unmet needs of patients suffering from neurological, cardio-vascular and aging conditions. The firm's flagship product NeuroAiD, helps patients recover faster and better from stroke disabilities. The company was founded by David Picard and Marc Vasseur in 2003 and is headquartered in Singapore. | Pharmaceuticals: Major | Director/Board Member | |
HUYA Bioscience International LLC
 HUYA Bioscience International LLC Pharmaceuticals: MajorHealth Technology HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| NOVARTIS AG | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Director/Board Member | |
Fujirebio Europe NV
 Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Medical Specialties | Chief Executive Officer | |
| MEDIGENE AG | Biotechnology | Director of Finance/CFO Director/Board Member Chief Tech/Sci/R&D Officer | |
Miles, Inc.
 Miles, Inc. Chemicals: Major DiversifiedProcess Industries Part of Bayer AG, Miles, Inc. is a chemical company. The company is based in Pittsburgh, PA. | Chemicals: Major Diversified | Corporate Officer/Principal | |
| Loyola Marymount University | College/University | Masters Business Admin | |
NOXXON Pharma AG
 NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Biotechnology | Chief Executive Officer | |
| University of Kiel | College/University | Doctorate Degree | |
| University of Cincinnati (Ohio) | College/University | Corporate Officer/Principal | |
| University of Maryland | College/University | Undergraduate Degree Undergraduate Degree | |
| Université de Montpellier | College/University | Doctorate Degree | |
| HEIDELBERG PHARMA AG | Pharmaceuticals: Major | Public Communications Contact Human Resources Officer General Counsel | |
| INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member | |
Takeda A/S
 Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Financial Conglomerates | Chief Executive Officer | |
| Swiss Federal Institute of Technology | College/University | Graduate Degree Corporate Officer/Principal | |
| Philipps University of Marburg | College/University | Doctorate Degree | |
| Ludwig-Maximilians-Universität München | College/University | Graduate Degree Doctorate Degree | |
| VIVORYON THERAPEUTICS N.V. | Biotechnology | Director/Board Member Director/Board Member | |
Takeda Pharmaceuticals International AG
 Takeda Pharmaceuticals International AG Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals International GmbH develops, manufactures, and distributes pharmaceutical products. It offers medicines in therapeutic areas, such as, cardiovascular and metabolic, oncology, central nervous system, respiratory and immunology, general medicine, and vaccines. The firm also provides packaging, development, contract manufacturing and quality control services. Takeda Pharmaceuticals International was founded in 1874 and is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Chief Executive Officer | |
Takeda Pharmaceuticals International, Inc.
 Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., Takeda Pharmaceuticals International, Inc. provides management consulting for pharmaceutical businesses. The company is based in Deerfield, IL. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Sanofi-Aventis Recherche et Développement SA
 Sanofi-Aventis Recherche et Développement SA Miscellaneous Commercial ServicesCommercial Services Sanofi-Aventis Recherche et Développement SA is a pharmaceutical company based in Chilly-Mazarin, France. Part of Sanofi, Sanofi-Aventis Recherche et Développement SA is a French company that focuses on delivering medicines and vaccines for millions of people around the world. The company's R & D teams work closely with patient communities affected by rare hematological disorders to offer them effective and innovative therapeutic care. Find out more about rare hematological disorders in R&D. The company was founded in 1900. Lionel Joël Bascles has been the CEO of the company since 2018. | Miscellaneous Commercial Services | Chief Executive Officer | |
Cristal Delivery BV
 Cristal Delivery BV Pharmaceuticals: MajorHealth Technology Cristal Delivery BV develops and manufactures nanomedicines for therapeutic drug optimization. It offers pipeline, oncology, and inflammation programs. The company was founded by Joost J. M. Holthuis and Cristianne Rijcken in April 2011 and is headquartered in Maastricht, the Netherlands. | Pharmaceuticals: Major | Chief Executive Officer | |
| C&F Consulting | Founder | ||
| CUE BIOPHARMA, INC. | Biotechnology | Chairman | |
Viewpoint Molecular Targeting, Inc.
 Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Viewpoint Molecular Targeting, Inc. develops pharmaceutical drugs for diagnostic imaging and therapy for cancer. The firm?s radiopharmaceutical drugs are designed to specifically localize in cancerous tissues in the human body. The company was founded by Frances L. Johnson, Michael K. Schultz and Heyward H. Coleman in 2008 and is headquartered in Coralville, IA. | Miscellaneous Commercial Services | Director/Board Member | |
Griffon Pharmaceuticals, Inc.
 Griffon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Griffon Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The private company is based in Montréal, Canada. | Pharmaceuticals: Major | Director/Board Member | |
| Viewpoint (US) | Director/Board Member | ||
| PERSPECTIVE THERAPEUTICS, INC. | Medical Specialties | Director/Board Member |
Estadísticas
Internacional
| Estados Unidos | 21 |
| Alemania | 14 |
| Francia | 7 |
| Suiza | 3 |
| Dinamarca | 3 |
Sectorial
| Health Technology | 31 |
| Consumer Services | 10 |
| Commercial Services | 5 |
| Process Industries | 2 |
| Finance | 2 |
Operativa
| Director/Board Member | 111 |
| Corporate Officer/Principal | 74 |
| Independent Dir/Board Member | 41 |
| Chairman | 39 |
| Chief Executive Officer | 24 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Daniel Camus | 31 |
| Karin Eastham | 29 |
| Wendy Johnson | 23 |
| David Lemus | 22 |
| Frank Morich | 21 |
| Hans Jörg Reinhardt | 20 |
| Geoffrey Nicholas Vernon | 17 |
| Klaus Kühn | 15 |
| Metin Colpan | 14 |
| Jens Holstein | 14 |
| Malte Peters | 11 |
| Rainer Kramer | 10 |
| Robert Friesen | 9 |
| Walter Blättler | 9 |
| Krisja Vermeylen | 8 |
- Bolsa de valores
- Insiders
- Marlies Sproll
- Conexiones Empresas
